Nvidia lines up minority stakes in French AI and healthcare startups, as its reported investment pipeline tops $51 billion

Nvidia has outlined planned investments in four French technology startups, a move that underscores how the company is extending beyond chips into applied artificial intelligence and software platforms. The announcements come as Nvidia’s broader “investment book” was reported to have surpassed $51 billion, according to the report that flagged the deals.

One of the targets is Doctolib, a France-based online healthcare scheduling and management platform. In comments carried by Reuters through a Doctolib statement, the company said Nvidia has agreed to acquire a minority stake. The disclosure indicates Nvidia is pursuing a presence that may be smaller than a full acquisition, while still giving it influence over a promising early-stage or growth company.

The investment plans also include Genesis AI, a French AI startup. The report characterizes the set of deals as Nvidia investments into specific companies rather than a broad fund mandate, suggesting a more hands-on approach to backing technology that can pair with Nvidia’s AI hardware and enterprise tools. In addition, Nvidia named Pigment and Entalpic as other French startup investments.

Pigment is described in the report as part of Nvidia’s technology investment list, but the available details do not spell out the product focus or the size or terms of the planned stake beyond the fact that it is part of Nvidia’s announced investment activity in France. Entalpic is similarly listed as one of the startups Nvidia plans to invest in, with no further deal structure details included in the available material.

The common theme across the named companies is that each is positioned in sectors where AI is increasingly being embedded into day-to-day operations. Healthcare workflows, enterprise planning and decision tools, and domain-specific industrial or scientific applications are areas where customers often want faster integration than they can get from generic models alone. Nvidia, which supplies the GPUs and computing infrastructure that many AI systems run on, has been building momentum through partnerships that translate its platforms into real-world software and services.

Nvidia’s “investment book” figure, reported to have topped $51 billion, points to how large its pipeline has become. While the specific meaning of the metric is not defined in the available report, the use of a single total suggests Nvidia aggregates announced or committed investments across multiple transactions. In practice, this kind of pipeline can serve as a bridge between Nvidia’s core business and the fast-changing ecosystem of AI start-ups and enterprise adopters.

The report also highlights that Nvidia’s strategy in these deals appears to blend minority stakes with the option to deepen relationships over time. Minority acquisitions can be attractive when a company wants exposure to a startup’s product trajectory without taking on the full execution and integration burden of an acquisition. In the Doctolib example, the minority-stake framing is explicit, but the precise ownership level, valuation, and governance rights are not provided in the available material.

What is not clear from the available information is the timing of each transaction, whether Nvidia has already closed the deals or is still negotiating final terms, and what Nvidia expects to receive beyond an equity position. The report also does not disclose any financial size for the Doctolib, Genesis AI, Pigment or Entalpic stakes, nor does it lay out how Nvidia’s role might translate into customer deployments, product bundling, or engineering collaboration. Those details are likely to emerge only after the companies publish fuller announcements or regulatory filings. Investors and customers may want to watch for follow-on statements that specify deal structure and strategic plans. (As of the publication date of the report: Oct. 13–14, 2026.)